Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ASND
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Ascendis Pharma A/S (ASND) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Ascendis Pharma (ASND) trades at $236.72, down 0.97% on the day, amid a bearish technical signal but strong analyst optimism. The stock shows robust revenue growth, with 2025 revenue reaching $720.13 million and a projected jump to $1.0 billion in 2026, though net losses persist. Recent developments include regaining TransCon technology rights and a $400 million share buyback program, signaling strategic shifts. Technical indicators point to oversold conditions with RSI at 24.75, while support sits at $234 and resistance at $241.
The outlook is mixed: strong revenue growth and high analyst buy ratings (92%) support upside potential, with a consensus price target of $317.42. However, persistent net losses, high debt levels, and bearish technical trends pose significant risks. Investors should weigh the company's growth trajectory against execution challenges and market sentiment shifts.
Read full analysis

Key Stats

  • Market Cap
    $15.63B
  • Volume
    810,373
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $189.74
  • Typical Hold Time
    55 Days
  • Enterprise Value
    $15.21B
  • Div Yield
    -
  • Trading Activity
    -
$235.42
52W Low: $189.74
25 Sep 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $189.74 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Most Recent News

Content is generated by Aura AI

Apple's new CEO faces pressure to drop Chinese chip deal amid rising memory costs and US political scrutiny

Apple's new CEO, John Ternus, is under pressure from Washington to abandon a Chinese memory chip deal that former CEO Tim Cook fought to maintain. This comes as Apple faces rising memory costs, which have significantly impacted iPhone pricing and pro...

Market News
4 hours ago
24/7 Wall Street
Neutral
Apple's new CEO faces pressure to drop Chinese chip deal amid rising memory costs and US political scrutiny

Domino's closes 13 Ohio stores abruptly, employees learn via text during dinner rush

Domino's abruptly closed 13 franchise-operated stores in Ohio, managed by Anthony Satterwhite, due to financial struggles. Employees were informed via text message during a busy dinner shift, causing immediate job losses and customer order disruption...

Market News
4 hours ago
New York Post
Bearish
news icon
Domino's closes 13 Ohio stores abruptly, employees learn via text during dinner rush

Kroger unveils AI strategy to enhance customer experience and operational efficiency in grocery shopping.

Kroger announced its AI strategy at GroceryShop 2026, focusing on improving customer experience, easing associate work, and driving better business outcomes. The company leverages extensive customer data and proprietary AI models for demand forecasti...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
Kroger unveils AI strategy to enhance customer experience and operational efficiency in grocery shopping.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $15.63B
  • Volume
    810,373
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $189.74
  • Typical Hold Time
    55 Days
  • Enterprise Value
    $15.21B
  • Div Yield
    -
  • Trading Activity
    -
$235.42
52W Low: $189.74
25 Sep 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $189.74 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!